PT  - JOURNAL ARTICLE
AU  - Wei Tang
AU  - Anca D Askanase
AU  - Leila Khalili
AU  - Joan T Merrill
TI  - SARS-CoV-2 vaccines in patients with SLE
AID  - 10.1136/lupus-2021-000479
DP  - 2021 Mar 01
TA  - Lupus Science & Medicine
PG  - e000479
VI  - 8
IP  - 1
4099  - http://lupus.bmj.com/content/8/1/e000479.short
4100  - http://lupus.bmj.com/content/8/1/e000479.full
SO  - Lupus Sci Med2021 Mar 01; 8
AB  - As the Moderna (mRNA-1273) and Pfizer/BioNTech (BNT162b2) vaccines become available to patients with autoimmune diseases and SLE, practitioners will have to inform them about the safety and efficacy of these vaccines. Here we discuss the challenges of applying vaccine data to patients with autoimmune diseases and the evidence available in the literature that may help in the decision process.